Shenzhen - Delayed Quote CNY

Teyi Pharmaceutical Group Co.,Ltd (002728.SZ)

8.70 +0.15 (+1.75%)

At close: October 30 at 3:04:21 PM GMT+8

Chart Range Bar

Loading chart for 002728.SZ

Previous Close 8.55
Open 8.48
Bid 8.70 x --
Ask 8.71 x --
Day's Range 8.40 - 9.13
52 Week Range 7.66 - 15.21
Volume 22,360,840
Avg. Volume 20,022,655
Market Cap (intraday) 4.466B
Beta (5Y Monthly) --
PE Ratio (TTM) 66.92
EPS (TTM) 0.13
Earnings Date --
Forward Dividend & Yield 0.15 (1.72%)
1y Target Est --
Moby Rating Neutral

Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People's Republic of China. The company's products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. The company was founded in 2002 and is based in Taishan, the People's Republic of China.

www.tczy.com.cn

1,434

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002728.SZ

18.31%

SSE Composite Index (000001.SS)

9.32%

1-Year Return

002728.SZ

15.90%

SSE Composite Index (000001.SS)

9.73%

3-Year Return

002728.SZ

24.59%

SSE Composite Index (000001.SS)

19.11%

5-Year Return

002728.SZ

59.15%

SSE Composite Index (000001.SS)

1.46%

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

7.70%
Return on Assets (ttm)

1.80%
Return on Equity (ttm)

3.66%
Revenue (ttm)

856.22M
Net Income Avi to Common (ttm)

65.9M
Diluted EPS (ttm)

0.13

Balance Sheet and Cash Flow

Total Cash (mrq)

491.6M
Total Debt/Equity (mrq)

21.52%
Levered Free Cash Flow (ttm)

72.99M

002737.SZ

002603.SZ

002758.SZ

002644.SZ

002317.SZ

U.S. markets closed

Teyi Pharmaceutical Group Co.,Ltd (002728.SZ)

-3.23%

-12.21%

-12.39%

-19.82%

-17.46%

39.09%

87.28%

Teyi Pharmaceutical Group Co.,Ltd Overview Drug Manufacturers - Specialty & Generic / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch